[1] 魏依兰, 申晓平, 杜录, 等.急性缺血性脑卒中患者血清成纤维细胞生长因子4水平变化及其与病情严重程度和预后的关系[J].山东医药, 2020, 60(9):60-62.
[2] 成旭静, 耿红艳, 刘新静.急性缺血性脑卒中患者血清HIF-1α、AQP9水平与出血转化的相关性分析[J].中风与神经疾病杂志, 2020, 37(3):227-231.
[3] CASTRO P, AZEVEDO E, SERRADOR J, et al.Hemorrhagic transformation and cerebral edema in acute ischemic stroke:Link to cerebral autoregulation[J].J Neurol Sci, 2017, 372(1):256-261.
[4] KNAPSKOG A B, HENJUM K, IDLAND A V, et al.Cerebrospinal fluid sTREM2 in Alzheimer's disease:comparisons between clinical presentation and AT classification[J].Sci Rep, 2020, 10(1):15886-15895.
[5] XU H, MU S, QINN W.Microglia TREM2 is required for electroacupuncture to attenuate neuroinflammation in focal cerebral ischemia/reperfusion rats[J].Biochem Biophys Res Commun, 2018, 503(4):3225-3234.
[6] 中华医学会神经病学分会, 中华医学会神经病学分会脑血管病学组.中国急性缺血性脑卒中诊治指南2018[J].中华神经科杂志, 2018, 51(9):666-682.
[7] 中华医学会神经病学分会脑血管病学组.中国急性脑梗死后出血转化诊治共识2019[J].中华神经科杂志, 2019, 52(4):252-265.
[8] LANGEL C, POPOVIC K S.Infarct-core CT perfusion parameters in predicting post-thrombolysis hemorrhagic transformation of acute ischemic stroke[J].Radiol oncol, 2018, 53(1):25-30.
[9] 张金枝, 王丽娟, 张潇, 等.急性缺血性脑卒中患者血清Sestrin2水平与病情严重程度及预后的相关性分析[J].河北医学, 2019, 25(2):259-262.
[10] SUAREZ-CALVET M, MORENAS-RODRíGUEZ E, KLEINBERGER G, et al.Early increase of CSF sTREM2 in Alzheimer's disease is associated with tau related-neurodegeneration but not with amyloid-β pathology[J].Mol Neurodegener, 2019, 14(1):1-14.
[11] SUÁREZ-CALVET M, CAPELL A, ARAQUE CABALLERO M Á, et al.CSF progranulin increases in the course of Alzheimer's disease and is associated with sTREM2, neurodegeneration and cognitive decline[J].EMBO Mol Med, 2018, 10(12):e9712.
[12] YANG J, FU Z, ZHANG X, et al.TREM2 ectodomain and its soluble form in Alzheimer's disease[J].J Neuroinflammation, 2020, 17(1):204-215.
[13] QIN C, ZHOU L Q, MA X T, et al.Dual functions of microglia in ischemic stroke[J].Neurosci Bull, 2019, 35(5):921-933.
[14] GUO Y, WEI X, YAN H, et al.TREM2 deficiency aggravates α-synuclein-induced neurodegeneration and neuroinflammation in Parkinson's disease models[J].FASEB J, 2019, 33(11):12164-12174.
[15] WU R, LI X, XU P, et al.TREM2 protects against cerebral ischemia/reperfusion injury[J].Mol Brain, 2017, 10(1):20-32.
[16] KANAZAWA M, NINOMIYA I, HATAKEYAMA M, et al.Microglia and monocytes/macrophages polarization reveal novel therapeutic mechanism against stroke[J].Int J Mol Sci, 2017, 18(10):2135-2152.
[17] GERVOIS P, LAMBRICHTS I.The emerging role of triggering receptor expressed on myeloid cells 2 as a target for immunomodulation in ischemic stroke[J].Front Immunol, 2019, 10:1668-1675.
[18] WANG Y, CHENG Y, SONG Q, et al.The association between monocyte to high-density lipoprotein ratio and hemorrhagic transformation in patients with acute ischemic stroke[J].Aging(Albany NY), 2020, 12(3):2498-2506.
[19] KWON H S, LEE E H, PARK H H, et al.Early increment of soluble triggering receptor expressed on myeloid cells 2 in plasma might be a predictor of poor outcome after ischemic stroke[J].J Clin Neurosci, 2020, 73:215-218. |